The French newspaper Le Figaro weighed in with its own insider account of the Sanofi-Genzyme merger talks, speculating that the deal could get wrapped up early next week--provided, of course, both sides continue to narrow the gap that exists between what Sanofi is willing to pay in cash and what it promises in milestones. Report